EICHOR
● Completed
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)
Condition: Active Psoriatic Arthritis · Sponsor: Sun Pharmaceutical Industries Limited
About this study
This is a multicenter Phase III, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of tildrakizumab in Subjects with Active Psoriatic Arthritis I (INSPIRE 1)
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (97)
| Sunpharma Site no 42 | Dothan, Alabama, United States | — |
| Sunpharma Site no 29 | Gilbert, Arizona, United States | — |
| Sunpharma Site no 30 | Glendale, Arizona, United States | — |
| Sunpharma Site no 31 | Mesa, Arizona, United States | — |
| Sunpharma Site no 35 | Covina, California, United States | — |
| Sunpharma Site no 48 | Encino, California, United States | — |
| Sunpharma site no. 17 | Fountain Valley, California, United States | — |
| Sunpharma site no. 15 | Thousand Oaks, California, United States | — |
| Sunpharma Site no. 141 | Avon Park, Florida, United States | — |
| Sunpharma site no. 21 | Clearwater, Florida, United States | — |
| Sunpharma site no. 02 | Hialeah, Florida, United States | — |
| Sunpharma Site no 55 | Kissimmee, Florida, United States | — |
+ 85 more locations — full list on the registry record.
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04314544